{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:00:16Z","timestamp":1782478816594,"version":"3.54.5"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Precision medicine in paediatric cardiac channelopathy and cardiomyopathy has a rapid advancement over the past years. Compared to conventional gene panel and exome-based testing, whole genome sequencing (WGS) offers additional coverage at the promoter, intronic regions and the mitochondrial genome. However, the data on use of WGS to evaluate the genetic cause of these cardiovascular conditions in children and adolescents are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a tertiary paediatric cardiology center, we recruited all patients diagnosed with cardiac channelopathy and cardiomyopathy between the ages of 0 and 18 years old, who had negative genetic findings with prior gene panel or exome-based testing. After genetic counselling, blood samples were collected from the subjects and both their parents for WGS analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 31 patients (11 cardiac channelopathy and 20 cardiomyopathy) were recruited. Four intronic splice-site variants were identified in three cardiomyopathy patients, which were not identified in previous whole exome sequencing. These included a pathogenic variant in <jats:italic>TAFAZZIN:c.284+5G&amp;gt;A<\/jats:italic> (Barth syndrome), a variant of unknown significance (VUS) in <jats:italic>MYBPC3:c.1224-80G&amp;gt;A<\/jats:italic> and 2 compound heterozygous LP variants in <jats:italic>LZTR1<\/jats:italic> (<jats:italic>LZTR1:c.1943-256C&amp;gt;T<\/jats:italic> and <jats:italic>LZTR1:c1261-3C&amp;gt;G<\/jats:italic>) in a patient with clinical features of RASopathy. There was an additional diagnostic yield of 1.94% using WGS for identification of intronic variants, on top of conventional gene testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>WGS plays a role in identifying additional intronic splice-site variants in paediatric patients with isolated cardiomyopathy. With the demonstrated low extra yield of WGS albeit its ability to provide potential clinically important information, WGS should be considered in selected paediatric cases of cardiac channelopathy and cardiomyopathy in a cost-effective manner.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1335527","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:20:43Z","timestamp":1710912043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole genome sequencing in paediatric channelopathy and cardiomyopathy"],"prefix":"10.3389","volume":"11","author":[{"given":"Sit Yee","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Ka Yee","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Zhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie Fong Ying","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C. Y.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Hon Yin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.12809\/hkmj187487","article-title":"Clinical and genetic profile of congenital long QT syndrome in Hong Kong: a 20-year experience in paediatrics","volume":"24","author":"Kwok","year":"2018","journal-title":"Hong Kong Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.12809\/hkmj154653","article-title":"Clinical and genetic profile of catecholaminergic polymorphic ventricular tachycardia in Hong Kong Chinese children","volume":"22","author":"Yu","year":"2016","journal-title":"Hong Kong Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/eurheartj\/ehy412","article-title":"SCN5A mutation in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups","volume":"39","author":"Baruteau","year":"2018","journal-title":"Eur Heart J"},{"key":"B5","first-page":"35","article-title":"Genetic spectrum of paediatric cardiomyopathy in Hong Kong","volume":"28","author":"Shi","year":"2020","journal-title":"J HK Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/ERP-16-0037","article-title":"Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British society of echocardiography","volume":"4","author":"Mathew","year":"2017","journal-title":"Echo Res Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/ERP-15-0007","article-title":"Diagnosis and management of hypertrophic cardiomyopathy","volume":"2","author":"Pantazis","year":"2015","journal-title":"Echo Res Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: association for European paediatric and congenital cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American college of medical genetics and genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criteria","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"Updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum Mutat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","article-title":"Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI splicing subgroup","volume":"110","author":"Walker","year":"2023","journal-title":"Am J Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"12","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","article-title":"Consideration of cosegregation in the pathogenicity classification of genomic variants","volume":"98","author":"Jarvik","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am J Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/humu.24416","article-title":"Guidelines for clinical interpretation of variant pathogenicity using RNA phenotypes","volume":"43","author":"Smirnov","year":"2022","journal-title":"Hum Mutat"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41436-020-00946-5","article-title":"Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls","volume":"23","author":"Walsh","year":"2021","journal-title":"Genet Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s inherited cardiomyopathy expert panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/gim.2018.3","article-title":"Clingen\u2019s RASopathy expert panel consensus methods for variant interpretation","volume":"20","author":"Gelb","year":"2018","journal-title":"Genet Med"},{"key":"B22","article-title":"ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2020","author":"Ellard","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41525-022-00347-4","article-title":"Diagnostic potential of the amniotic fluid cells transcriptome in deciphering Mendelian disease: a proof-of-concept","volume":"7","author":"Lee","year":"2022","journal-title":"NPJ Genom Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e002905","DOI":"10.1161\/CIRCGEN.120.002905","article-title":"Cryptic splice-altering variants in MYBPC3 are a prevalent cause of hypertrophic cardiomyopathy","volume":"13","author":"Lopes","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/humu.23944","article-title":"Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy","volume":"41","author":"Janin","year":"2020","journal-title":"Hum Mutat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.3390\/ijms241310510","article-title":"An update on MYBPC3 gene mutation in hypertrophic cardiomyopathy","volume":"24","author":"Udurachi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s44161-023-00346-3","article-title":"Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies","volume":"2","author":"Lipov","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","article-title":"Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants","volume":"20","author":"Johnston","year":"2018","journal-title":"Genet Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.119.044794","article-title":"Intronic CRISPR repair in a preclinical model of Noonan syndrome-associated cardiomyopathy","volume":"142","author":"Hanses","year":"2020","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.7717\/peerj.13265","article-title":"Whole mitochondrial genome sequencing of Malaysian patients with cardiomyopathy","volume":"10","author":"Kuan","year":"2022","journal-title":"PeerJ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13073-019-0616-z","article-title":"Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy","volume":"11","author":"Walsh","year":"2019","journal-title":"Genome Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.hrthm.2022.02.004","article-title":"Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic kcnh2 variant","volume":"19","author":"Tobert","year":"2022","journal-title":"Heart Rhythm"},{"key":"B33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10741-020-10031-3","article-title":"Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide","volume":"26","author":"Sabbah","year":"2021","journal-title":"Heart Fail Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/joa3.12717","article-title":"European Heart rhythm association (EHRA)\/heart rhythm society (HRS)\/Asia pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases","volume":"38","author":"Wilde","year":"2022","journal-title":"J Arrhythm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41436-020-01006-8","article-title":"A phase 2\/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism","volume":"23","author":"Reid Thompson","year":"2021","journal-title":"Genet Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome","volume":"126","author":"Wang","year":"2020","journal-title":"Circ Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e000054","DOI":"10.1161\/HCG.0000000000000054","article-title":"Establishment of specialized clinical cardiovascular genetic programs: recognizing the need and meeting standards. A scientific statement from the American heart association","volume":"12","author":"Ahmad","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/gim.2017.212","article-title":"Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience","volume":"20","author":"Bland","year":"2018","journal-title":"Genet Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ng.2712","article-title":"Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death","volume":"45","author":"Bezzina","year":"2013","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e002911","DOI":"10.1161\/CIRCGEN.120.002911","article-title":"SCN5A mutation type and a genetic risk score associate variably with Brugada syndrome phenotype in SCN5A families","volume":"13","author":"Wijeyeratne","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","article-title":"Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility","author":"Barc","year":"2022","journal-title":"Nat Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.120.045956","article-title":"Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome","volume":"142","author":"Lahrouchi","year":"2020","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/cvr\/cvab153","article-title":"Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?","volume":"117","author":"Kany","year":"2021","journal-title":"Cardiovasc Resm"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1335527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T16:39:35Z","timestamp":1711125575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1335527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2024.1335527"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1335527","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"1335527"}}